lithium carbonate has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunetti, A; Capasso, G; Cervo, A; Cocozza, S; de Leva, M; De Michele, G; Filla, A; Marsili, A; Morra, VB; Pane, C; Puorro, G; Quarantelli, M; Russo, CV; Saccà, F; Trepiccione, F | 1 |
| Atkinson, R; Emamian, E; Gatchel, JR; Mizusawa, H; Orr, HT; Richman, R; Shaw, C; Sun, Y; Watase, K; Zoghbi, HY | 1 |
1 trial(s) available for lithium carbonate and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2.
Topics: Adult; Atrophy; Autophagy; Brain; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lithium Carbonate; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Spinocerebellar Ataxias; Treatment Outcome | 2015 |
1 other study(ies) available for lithium carbonate and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
Topics: Animals; Antimanic Agents; Ataxin-1; Ataxins; Dendrites; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Lithium Carbonate; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Phosphorylation; Protein Methyltransferases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Spinocerebellar Ataxias | 2007 |